← Back to Search

Extracorporeal Therapy

CytoSorb Device for Rhabdomyolysis

Phase 2
Waitlist Available
Led By LTC Kevin Chung, MD
Research Sponsored by CytoSorbents, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial looks at whether using CytoSorb, a device that removes toxins from the blood, in addition to the standard care for rhabdomyolysis, is feasible and effective.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment of serious device or procedure-related adverse events
Efficacy of device as measured by change in myoglobin

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CytoSorb DeviceExperimental Treatment1 Intervention
Group II: CVVHActive Control1 Intervention

Find a Location

Who is running the clinical trial?

San Antonio Military Medical Center (SAMMC), US Army Institute of Surgical Research-Burn CenterUNKNOWN
CytoSorbents, IncLead Sponsor
16 Previous Clinical Trials
4,525 Total Patients Enrolled
1 Trials studying Rhabdomyolysis
3,000 Patients Enrolled for Rhabdomyolysis
LTC Kevin Chung, MDPrincipal InvestigatorSan Antonio Military Medical Center-US Army Institute of Surgical Research-Burn Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the CytoSorb Device been given clearance by the FDA?

"While there is limited clinical data indicating the safety of CytoSorb Device, no evidence exists to support its efficacy. Thus, we at Power rated it a 2 on our scale from 1-3."

Answered by AI

Do I conform to the criteria for enrollment in this experiment?

"This medical trial is searching for 30 participants aged between 18-80 suffering from rhabdomyolysis. Applicants must adhere to the following conditions: age range, a clinical diagnosis of rhabdomyolysis, in need of renal replacement therapy and volume resuscitation, as well as willing to meet follow up requirements."

Answered by AI

Are individuals being accepted for this research endeavor at the present time?

"Clinicaltrials.gov reports that this medical trial, initially posted on March 1st 2014, is not presently seeking patients. Nonetheless, there are two other trials actively enrolling subjects at the current time."

Answered by AI

Is eligibility for this study restricted to individuals under 45 years of age?

"As specified by the trial's eligibility requirements, individuals must have attained 18 years of age and not be more than 80 to participate."

Answered by AI

Who else is applying?

What state do they live in?
Arkansas
Texas
How old are they?
18 - 65
What site did they apply to?
San Antonio Military Medical Center- US Army Institute of Surgical Research- Burn Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis
2014. "Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02111018.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top